Search

everythinglearnresearchcommunity

for

Search:↓

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

Children's screen time increased during the pandemic, causing various health issues.

COVID-19 infection may trigger alopecia areata in some patients.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Covid-19 can cause hair loss due to immune and psychological factors.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Hair loss doesn't affect COVID-19 severity.

Many doctors lack knowledge about COVID-19 skin symptoms and need better education and guidelines.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

COVID-19 infection may cause hair loss.

COVID-19 patients with hair loss experienced greater cognitive deficits and more symptoms of depression, anxiety, and stress.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

COVID-19 may cause temporary hair loss due to the body's immune response.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 infection can significantly cause temporary hair loss.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.